Sanofi may appeal French competition body fine
PARIS May 14 (Reuters) - French drugmaker Sanofi said on Tuesday it objected to a fine by the French Competition Authority in a dispute over generic competition to its blood thinner, Plavix, and said it was considering a possible appeal.
The Competition Authority said it fined Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to Plavix. ($1 = 0.7703 euros) (Reporting by Dominique Vidalon; Editing by James Regan)
- Exclusive: Malaysia plane probe narrows on mid-air disintegration - source
- Radar showed missing plane may have turned back: Malaysia military
- Missing Malaysian jet may have disintegrated in mid-air: source |
- Malaysian plane presumed crashed; questions over false IDs |
- Merkel raps Putin as Russian forces tighten grip on Crimea |